New Pharmacology Strategies to Control Resistant Hypertension - Atul Pathak

↳ This is a section part of Moment: CRT 2017 : RENAL DENERVATION & HYPERTENSION THERAPIES - Hypertension Definition, Pathophysiology, New Targets and Medical Therapy

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

New Pharmacology Strategies to Control Resistant Hypertension - Atul Pathak at CRT 2017.

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

Learning Objectives

Other Components in this Moment

Overview
Uncontrolled Hypertension Versus Resistant Hypertension: Prevalence, Prognosis and Treatment - Judith Veis
New Targets for Optimal Blood Pressure European Versus US Guidelines - Thomas Luescher
Impact of Baseline Blood Pressure and Age on Controlling Blood Pressure - Michael Weber
Systematic Evaluation of Haemodynamic Parameters to Predict Haemodynamic Responders to Renal Artery Denervation - Justin Davies
New Pharmacology Strategies to Control Resistant Hypertension - Atul Pathak
Loading Simple Education